Economic news

Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

2025.01.27 13:13

Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

Source link

Related Articles

Back to top button